Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long [Yahoo! Finance]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Yahoo! Finance
AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. On 31 December 2023, the US$352m market-cap company posted a loss of US$22m for its most recent financial year. The most pressing concern for investors is AxoGen's path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate. See our latest analysis for AxoGen AxoGen is bordering on breakeven, according to the 5 American Medical Equipment analysts. They expect the company to post a final loss in 2025, before turning a profit of US$12m in 2026. The company is therefore projected to breakeven around 2 years from now. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 71%, which signals high confidence from analyst
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ [Yahoo! Finance]Yahoo! Finance
- Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™GlobeNewswire
- Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024GlobeNewswire
- Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) [Yahoo! Finance]Yahoo! Finance
- US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 3/5/24 - Beat
AXGN
Sec Filings
- 4/30/24 - Form EFFECT
- 4/24/24 - Form DEF
- 4/24/24 - Form ARS
- AXGN's page on the SEC website